OMB APPROVAL
OMB Number: 3235-0287
Expires December 31, 2001
Estimated average burden
hours per response...........0.5
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
[_] Check box if no longer subject of Section 16. Form 4 or Form 5 obligations
may continue. See Instruction 1(b).
________________________________________________________________________________
1. Name and Address of Reporting Person*
Credit Suisse First Boston,
on behalf of the Credit Suisse First Boston business unit
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
11 Madison Avenue
- --------------------------------------------------------------------------------
(Street)
New York NY 10010
- --------------------------------------------------------------------------------
(City) (State) (Zip)
________________________________________________________________________________
2. Issuer Name and Ticker or Trading Symbol
Charles River Laboratories International, Inc. (CRL)
________________________________________________________________________________
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)
________________________________________________________________________________
4. Statement for Month/Year
March 2001
________________________________________________________________________________
5. If Amendment, Date of Original (Month/Year)
================================================================================
6. Relationship of Reporting Person to Issuer
(Check all applicable)
[_] Director [X] 10% Owner
[_] Officer (give title below) [_] Other (specify below)
________________________________________________________________________________
7. Individual or Joint/Group Filing (Check applicable line)
[X] Form filed by one Reporting Person
[_] Form filed by more than one Reporting Person
________________________________________________________________________________
================================================================================
Table I -- Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
================================================================================
6.
4. 5. Owner-
Securities Acquired (A) or Amount of ship
3. Disposed of (D) Securities Form: 7.
Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of
2. Code ------------------------------- Owned at End (D) or Indirect
1. Transaction (Instr. 8) (A) of Month Indirect Beneficial
Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) (mm/dd/yy) Code V (D) and 4) (Instr.4) (Instr. 4)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 1,572,440 D 4,607,896 (I) (1)(13)(16)
(18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 62,621 D 183,508 (I) (2)(13)(16)
(18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 77,324 D 226,592 (I) (3)(13)(16)
(18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 91,932 D 269,396 (I) (4)(14)(16)
(18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 34,141 D 100,046 (I) (5)(14)(16)
(18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 320,783 D 940,028 (I) (6)(16)
(18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 25,424 D 74,505 (I) (7)(13)(16)
(18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 4,961 D 14,528 (I) (8)(13)(16)
(18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 7,060 D 20,690 (I) (9)(15)
(18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 621,857 D 2,065,640 (I) (11)(15)
(18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 2,586 D 9,305 (I) (12)(15)
(18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 177,165 D 638,757 (I) (18)(19)(21)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 10,630 D 38,326 (I) (18)(19)(22)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 395,253 D 1,425,065 (I) (16)(18)(19)
(23)(27)(28)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 56,324 D 177,317 (I) (16)(18)
(19)(24)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 3/21/01 S 592 D 2,131 (I) (18)(19)(20)
- ------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the Form is filed by more than one Reporting Person, see Instruction
4(b)(v).
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB control number.
SEC 1474 (3-99)
FORM 4 (continued)
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
10.
9. Owner-
Number ship
of Form
2. Deriv- of
Conver- 5. 7. ative Deriv- 11.
sion Number of Title and Amount Secur- ative Nature
or Derivative 6. of Underlying 8. ities Secur- of
Exer- 4. Securities Date Securities Price Bene- ity: In-
cise 3. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct
Price Trans- action or Disposed Expiration Date ---------------- Deriv- Owned (D) or Bene-
1. of action Code of(D) (Month/Day/Year) Amount ative at End In- ficial
Title of Deriv- Date (Instr. (Instr. 3, ---------------- or Secur- of direct Owner-
Derivative ative (Month/ 8) 4 and 5) Date Expira- Number ity Month (I) ship
Security Secur- Day/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr.
(Instr. 3) ity Year) Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $0.01 Immed. 04/01/10 Common 1,061,462 1,061,462(+) (I) (1) (13)
Stock (16)(18)
(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $0.01 Immed. 04/01/10 Common 42,264 42,264(+) (I) (2) (13)
Stock (16)(18)
(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $0.01 Immed. 04/01/10 Common 52,183 52,183(+) (I) (3) (13)
Stock (16)(18)
(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $0.01 Immed. 04/01/10 Common 62,053 62,053(+) (I) (4) (14)
Stock (16)(18
(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $0.01 Immed. 04/01/10 Common 23,039 23,039(+) (I) (5) (14)
Stock (16)(18)
(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $0.01 Immed. 04/01/10 Common 190,746 190,746(+) (I) (6) (16)
Stock (18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $0.01 Immed. 04/01/10 Common 17,158 17,158(+) (I) (7) (13)
Stock (16)(18)
(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $0.01 Immed. 04/01/10 Common 3,349 3,349(+) (I) (8) (13)
Stock (16)(18)
(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $0.01 Immed. 04/01/10 Common 4,781 4,781(+) (I) (9) (15)
Stock (18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $0.01 Immed. 04/01/10 Common 225,974 225,974(+) (I) (11)(15)
Stock (18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $0.01 Immed. 04/01/10 Common 2,040 2,040(+) (I) (12)(15)
Stock (18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $5.19 10/21/01 10/01/09 Common 20,102 20,102 +) (I) (11)(15)
Stock (18)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $5.19 10/21/01 10/01/09 Common 184,167 184,167(+) (I) (16)(18)
Stock (19)(23)
(27)(28)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $5.19 10/21/01 10/01/09 Common 23,943 23,943(+) (I) (16)(18)
Stock (19)(24)
- ------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:
(+) This number represents the aggregate number of shares of Common Stock
underlyingthe Warrants beneficially owned at the end of the month. See
Attachment A for footnotes:
Credit Suisse First Boston, acting solely on behalf of
the Credit Suisse First Boston business unit
/s/ Lindsay Hollister 4/10/01
- --------------------------------------------- ---------
By: Lindsay Hollister, Director Date
**Signature of Reporting Person
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB number.
Attachment A
Explanation of Responses
(1) These securities are held directly by DLJ Merchant Banking Partners II,
L.P. ("Partners II"), which is a partnership, and indirectly through its
interest in CRL Acquisition LLC, a limited liability company.
(2) These securities are held directly by DLJ Merchant Banking Partners II-A,
L.P., ("Partners II-A"), which is a partnership, and indirectly through
its interest in CRL Acquisition LLC, a limited liability company.
(3) These securities are held directly by DLJ Offshore Partners II, C.V.
("Offshore Partners II"), which is a partnership, and indirectly through
its interest in CRL Acquisition LLC, a limited liability company.
(4) These securities are held directly by DLJ Diversified Partners, L.P.
("Diversified"), which is a partnership, and indirectly through its
interest in CRL Acquisition LLC, a limited liability company.
(5) These securities are held directly by DLJ Diversified Partners-A, L.P.
("Diversified-A"), which is a partnership, and indirectly through its
interest in CRL Acquisition LLC, a limited liability company.
(6) These securities are held directly by DLJMB Funding II, Inc. ("Funding
II"), which is a Delaware corporation, and indirectly through its interest
in CRL Acquisition LLC, a limited liability company.
(7) These securities are held directly by DLJ Millennium Partners, L.P.
("Millennium"), which is a partnership, and indirectly through its
interest in CRL Acquisition LLC, a limited liability company.
(8) These securities are held directly by DLJ Millennium Partners-A, L.P.
("Millennium-A"), which is a partnership, and indirectly through its
interest in CRL Acquisition LLC, a limited liability company.
(9) These securities are held directly by DLJ EAB Partners, L.P. ("EAB"),
which is a partnership, and indirectly through its interest in CRL
Acquisition LLC, a limited liability company.
(10) (Intentionally omitted.)
(11) These securities are held directly by DLJ ESC II, L.P. ("ESC II"), which
is a partnership, and indirectly through its interest in CRL Acquisition
LLC, a limited liability company.
(12) These securities are held directly by DLJ First ESC, L.P. ("ESC"), which
is a partnership, and indirectly through its interest in CRL Acquisition
LLC, a limited liability company.
(13) DLJ Merchant Banking II, Inc. ("MB II INC") is the Managing General
Partner of each of Partners II, Partners II-A, Millennium, and
Millennium-A and Advisory General Partner of Offshore Partners II. In
addition, DLJ Merchant Banking II, LLC ("MB II LLC") is the Associate
General Partner of each of Partners II, Partners II-A, Offshore Partners
II, Millennium, Millennium-A, and EAB. MB II INC is also the Managing
Member of MB II LLC.
(14) DLJ Diversified Partners, Inc. ("Diversified Partners") is the General
Partner of each of Diversified and Diversified-A. DLJ Diversified
Associates, L.P. ("Diversified Associates") is the Associate General
Partner of each of Diversified and Diversified-A. Diversified Partners is
also the General Partner of Diversified Associates.
(15) DLJ LBO Plans Management Corporation is the Managing General Partner of
EAB, ESC and ESC II.
(16) DLJ Capital Investors, Inc. ("DLJCI") is the sole stockholder of each of
MB II INC, Diversified Partners, Funding II and DLJ Investment Funding,
Inc. ("IP Funding").
(17) (Intentionally omitted.)
(18) Credit Suisse First Boston (USA) Inc. ("CSFB-USA"), a Delaware corporation
formerly named Donaldson, Lufkin & Jenrette, Inc., is the parent of each
of DLJCC, DLJCI and DLJ LBO Plans Management Corporation.
(19) This Form 4 is being filed by Credit Suisse First Boston (the "Bank"), a
Swiss bank, on behalf of itself and its subsidiaries, to the extent that
they constitute part of the Credit Suisse First Boston business unit (the
"CSFB business unit" or the "Reporting Person"). The CSFB business unit is
engaged in the corporate and investment banking, trading (equity, fixed
income and foreign exchange), private equity investment and derivatives
businesses on a worldwide basis. The Bank and its subsidiaries engage in
other separately managed activities, most of which constitute the
independently operated Credit Suisse Asset Management business unit; the
Credit Suisse Asset Management business unit provides asset management and
investment advisory services to institutional investors worldwide.
Credit Suisse First Boston, Inc. ("CSFBI"), a Delaware corporation, owns
100% of the voting stock of CSFB-USA. The Bank owns a majority of the
voting stock, and all of the non-voting stock, of CSFBI. The ultimate
parent company of the Bank and CSFBI, and the direct owner of the
remainder of the voting stock of CSFBI, is Credit Suisse Group, a
corporation formed under the laws of Switzerland ("CSG").
The principal business of CSG is acting as a holding company for a global
financial services group with five distinct specialized business units
that are independently operated. In addition to the two business units
referred to above, CSG and its consolidated subsidiaries (other than the
Bank and its subsidiaries) are comprised of (a) the Credit Suisse Private
Bank business unit that engages in the global private banking business;
(b) the Credit Suisse business unit that engages in the Swiss domestic
banking business and (c) the Winterthur business unit that engages in the
global insurance business. CSG's business address is Paradeplatz 8,
Postfach 1, CH-8070, Zurich, Switzerland.
CSG, for purposes of federal securities laws, may be deemed ultimately to
control the Bank, and the CSFB business unit. CSG, its executive officers
and directors, and its direct and indirect subsidiaries (including all of
the business units except the CSFB business unit), may beneficially own
securities issued by the Issuer or derivative securities relating thereto,
and any such securities are not reported in this statement. Due to the
separate management and independent operation of its business units, CSG
disclaims beneficial ownership of any such securities beneficially owned
by its direct and indirect subsidiaries, including the Reporting Person.
The Reporting Person disclaims beneficial ownership of any such securities
beneficially owned by CSG and any of CSG's and the Bank's other business
units.
The Reporting Person disclaims beneficial ownership of securities held
directly by any entity described herein except with respect to the
Reporting Person's proportionate interest in or ownership of such entity.
The filing of this statement shall not be construed for purposes of
Section 16 of the Securities Exchange Act of 1934, as amended, as an
admission of beneficial ownership of the securities reported on this
statement.
(20) These securities are held directly by DLJCC, which is a corporation, and
indirectly through its interest in CRL Acquisition LLC, a limited
liability company.
(21) These securities are held directly by Sprout Capital VIII, L.P. ("Sprout
VIII"), which is a partnership, and indirectly through its interest in CRL
Acquisition LLC, a limited liability company. DLJCC is the Managing
General Partner of Sprout VIII.
(22) These securities are held directly by Sprout Venture Capital, L.P.
("Sprout"), which is a partnership, and indirectly through its interest in
CRL Acquisition LLC, a limited liability company. DLJCC is the general
partner of Sprout.
(23) These securities are held directly by DLJ Investment Partners, L.P.
("DLJIP"), which is a partnership, and indirectly through its interest in
CRL Acquisition LLC, a limited liability company.
(24) These securities are held directly by IP Funding, and indirectly through
its interest in CRL Acquisition LLC, a limited liability company.
(25) (Intentionally omitted.)
(26) (Intentionally omitted.)
(27) DLJ Investment Partners, Inc. is the general partner of DLJIP.
(28) IP Funding is the sole shareholder of DLJ Investment Partners, Inc.
